Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
Brunner, H. I., Ruperto, N., Tzaribachev, N., Horneff, G., Chasnyk, V. G., Panaviene, V., Abud-Mendoza, C., Reiff, A., Alexeeva, E., Rubio-Pérez, N., Keltsev, V., Kingsbury, D. J., del Rocio Maldonado Velázquez, M., Nikishina, I., Silverman, E. D., Joos, R., Smolewska, E., Bandeira, M., Minden, K., et al. (2018). Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial. Annals of the Rheumatic Diseases, 77(1), 21-29. https://doi.org/10.1136/annrheumdis-2016-210456 (Original work published 2017)